Doximity vs Hinge Health
DOCS and HNGE side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DOCS and HNGE compare
Hinge Health is the larger company, worth 1.6 times as much as Doximity ($9.2B against $5.8B).
Hinge Health grew revenue faster over the last twelve months (49.8% versus 11.2% for Doximity).
Doximity keeps more of each dollar of sales as profit, with a net margin of 25.5% compared with 15.1% at Hinge Health.
Doximity scores higher on the StockData Score (17 against 11 for Hinge Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DOCS | HNGE |
|---|---|---|
| Size and price | ||
| Market cap | $5.8B | $9.2B |
| Share price | $32.76 | $114.32 |
| Change, 1 year | −50.9% | 130% |
| Change, 5 years | −51.7% | – |
| Beta (5Y) | 1.66 | 1.68 |
| Employees | 880 | 1,437 |
| StockData Score | ||
| Total score | 17 (better) | 11 |
| Valuation score | 2 (better) | 0 |
| Growth score | 4 (better) | 3 |
| Performance score | 5 (better) | 2 |
| Health score | 6 | 6 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 38.5× | – |
| P/S | 8.9× (better) | 12.8× |
| P/B | 6.4× (better) | 26.8× |
| EV/EBITDA | 26.5× (better) | 89.8× |
| P/FCF | – | 31.8× |
| PEG | 1.69 | – |
| FCF yield | – | 3.1% |
| Fair value | $30.06 | – |
| Margin of safety | −9.0% | – |
| Growth | ||
| Revenue growth (TTM) | 11.2% | 49.8% (better) |
| Revenue growth, 5Y average | 25.5% | – |
| Net income growth (TTM) | −29.0% | – |
| EPS growth (TTM) | −27.4% | – |
| EPS growth, 5Y average | 33.6% | – |
| Profitability | ||
| Gross margin | 88.1% (better) | 84.5% |
| Operating margin | 29.6% (better) | 13.0% |
| Net margin | 25.5% (better) | 15.1% |
| FCF margin | – | 40.3% |
| Return on equity | 17.2% | 42.1% (better) |
| Return on invested capital | 18.7% | – |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 6.08 (better) | 1.34 |
| Altman Z-score | 22.77 (better) | 11.29 |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Buyback yield | 6.9% | – |
| Shareholder yield | 6.9% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 71.6% | 72.0% |
| Held by insiders | 33.6% | 50.7% |
| Insider net buying, 12 months | −$2.0M (better) | −$517M |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 9.5% | 15.9% |
Go deeper
- DOCS stock overview
- DOCS income statement
- DOCS valuation and score
- HNGE stock overview
- HNGE income statement
- HNGE valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.